nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—Ulcer—Alendronate—osteoporosis	0.00825	0.00977	CcSEcCtD
Carbachol—PLA2G4A—Estradiol—Estropipate—osteoporosis	0.00814	0.418	CbGdCrCtD
Carbachol—Ulcer—Ibandronate—osteoporosis	0.00804	0.00951	CcSEcCtD
Carbachol—Abdominal cramps—Conjugated Estrogens—osteoporosis	0.00776	0.00918	CcSEcCtD
Carbachol—Necrosis—Conjugated Estrogens—osteoporosis	0.00667	0.0079	CcSEcCtD
Carbachol—Ulcer—Risedronate—osteoporosis	0.00662	0.00784	CcSEcCtD
Carbachol—Abscess—Conjugated Estrogens—osteoporosis	0.00662	0.00783	CcSEcCtD
Carbachol—Arrhythmia—Calcium Acetate—osteoporosis	0.00626	0.00741	CcSEcCtD
Carbachol—Abdominal cramps—Estradiol—osteoporosis	0.00621	0.00735	CcSEcCtD
Carbachol—PLA2G4A—Estradiol—Conjugated Estrogens—osteoporosis	0.00617	0.317	CbGdCrCtD
Carbachol—Tenderness—Conjugated Estrogens—osteoporosis	0.006	0.0071	CcSEcCtD
Carbachol—Extravasation—Conjugated Estrogens—osteoporosis	0.006	0.0071	CcSEcCtD
Carbachol—Hyperkalaemia—Pamidronate—osteoporosis	0.00585	0.00692	CcSEcCtD
Carbachol—Asthma—Etidronic acid—osteoporosis	0.00575	0.0068	CcSEcCtD
Carbachol—Ulcer—Conjugated Estrogens—osteoporosis	0.00554	0.00655	CcSEcCtD
Carbachol—Syncope—Calcium Acetate—osteoporosis	0.00547	0.00648	CcSEcCtD
Carbachol—Loss of consciousness—Calcium Acetate—osteoporosis	0.00536	0.00635	CcSEcCtD
Carbachol—Hyperkalaemia—Zoledronate—osteoporosis	0.00534	0.00632	CcSEcCtD
Carbachol—Cramp muscle—Estropipate—osteoporosis	0.00518	0.00613	CcSEcCtD
Carbachol—PLA2G4A—Estradiol—Ethinyl Estradiol—osteoporosis	0.00518	0.266	CbGdCrCtD
Carbachol—Cramp muscle—Alendronate—osteoporosis	0.0051	0.00604	CcSEcCtD
Carbachol—Phlebitis—Pamidronate—osteoporosis	0.00502	0.00594	CcSEcCtD
Carbachol—Asthma—Estropipate—osteoporosis	0.00497	0.00589	CcSEcCtD
Carbachol—Cramp muscle—Ibandronate—osteoporosis	0.00497	0.00588	CcSEcCtD
Carbachol—Eye irritation—Estradiol—osteoporosis	0.00491	0.00581	CcSEcCtD
Carbachol—Shock—Calcium Acetate—osteoporosis	0.0049	0.0058	CcSEcCtD
Carbachol—Asthma—Alendronate—osteoporosis	0.0049	0.0058	CcSEcCtD
Carbachol—Tenderness—Estradiol—osteoporosis	0.0048	0.00569	CcSEcCtD
Carbachol—Asthma—Ibandronate—osteoporosis	0.00477	0.00564	CcSEcCtD
Carbachol—Abdominal discomfort—Estropipate—osteoporosis	0.00477	0.00564	CcSEcCtD
Carbachol—Abdominal discomfort—Alendronate—osteoporosis	0.0047	0.00556	CcSEcCtD
Carbachol—Hypotension—Calcium Acetate—osteoporosis	0.00465	0.00551	CcSEcCtD
Carbachol—Abdominal discomfort—Ibandronate—osteoporosis	0.00457	0.00541	CcSEcCtD
Carbachol—Ulcer—Estradiol—osteoporosis	0.00443	0.00524	CcSEcCtD
Carbachol—Phlebitis—Conjugated Estrogens—osteoporosis	0.00441	0.00522	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Pamidronate—osteoporosis	0.00432	0.00512	CcSEcCtD
Carbachol—Pain—Calcium Acetate—osteoporosis	0.00426	0.00504	CcSEcCtD
Carbachol—Sweating—Raloxifene—osteoporosis	0.00412	0.00487	CcSEcCtD
Carbachol—Sweating—Ibandronate—osteoporosis	0.00408	0.00482	CcSEcCtD
Carbachol—Flatulence—Etidronic acid—osteoporosis	0.00395	0.00467	CcSEcCtD
Carbachol—Asthma—Risedronate—osteoporosis	0.00393	0.00465	CcSEcCtD
Carbachol—Cramp muscle—Pamidronate—osteoporosis	0.00389	0.00461	CcSEcCtD
Carbachol—Muscle spasms—Etidronic acid—osteoporosis	0.00385	0.00456	CcSEcCtD
Carbachol—Abdominal discomfort—Risedronate—osteoporosis	0.00377	0.00446	CcSEcCtD
Carbachol—Pain—Ergocalciferol—osteoporosis	0.00376	0.00445	CcSEcCtD
Carbachol—Sweating increased—Pamidronate—osteoporosis	0.00364	0.00431	CcSEcCtD
Carbachol—Flushing—Raloxifene—osteoporosis	0.00358	0.00424	CcSEcCtD
Carbachol—Cramp muscle—Zoledronate—osteoporosis	0.00356	0.00421	CcSEcCtD
Carbachol—Phlebitis—Estradiol—osteoporosis	0.00353	0.00418	CcSEcCtD
Carbachol—Cramp muscle—Conjugated Estrogens—osteoporosis	0.00342	0.00405	CcSEcCtD
Carbachol—Flatulence—Estropipate—osteoporosis	0.00341	0.00404	CcSEcCtD
Carbachol—Asthma—Zoledronate—osteoporosis	0.00341	0.00404	CcSEcCtD
Carbachol—Diarrhoea—Calcium Acetate—osteoporosis	0.00341	0.00403	CcSEcCtD
Carbachol—Flatulence—Alendronate—osteoporosis	0.00336	0.00398	CcSEcCtD
Carbachol—Arrhythmia—Calcitriol—osteoporosis	0.00334	0.00395	CcSEcCtD
Carbachol—Muscle spasms—Estropipate—osteoporosis	0.00333	0.00394	CcSEcCtD
Carbachol—Sweating increased—Zoledronate—osteoporosis	0.00332	0.00393	CcSEcCtD
Carbachol—Flatulence—Raloxifene—osteoporosis	0.00331	0.00391	CcSEcCtD
Carbachol—Dizziness—Calcium Acetate—osteoporosis	0.00329	0.0039	CcSEcCtD
Carbachol—Asthma—Conjugated Estrogens—osteoporosis	0.00329	0.00389	CcSEcCtD
Carbachol—Muscle spasms—Alendronate—osteoporosis	0.00328	0.00388	CcSEcCtD
Carbachol—Flatulence—Ibandronate—osteoporosis	0.00327	0.00388	CcSEcCtD
Carbachol—Abdominal discomfort—Zoledronate—osteoporosis	0.00327	0.00387	CcSEcCtD
Carbachol—Infection—Etidronic acid—osteoporosis	0.00325	0.00384	CcSEcCtD
Carbachol—Muscle spasms—Raloxifene—osteoporosis	0.00323	0.00382	CcSEcCtD
Carbachol—Sweating increased—Conjugated Estrogens—osteoporosis	0.0032	0.00379	CcSEcCtD
Carbachol—Muscle spasms—Ibandronate—osteoporosis	0.00319	0.00378	CcSEcCtD
Carbachol—Vomiting—Calcium Acetate—osteoporosis	0.00317	0.00375	CcSEcCtD
Carbachol—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.00315	0.00373	CcSEcCtD
Carbachol—Syncope—Raloxifene—osteoporosis	0.00301	0.00356	CcSEcCtD
Carbachol—Nausea—Calcium Acetate—osteoporosis	0.00296	0.0035	CcSEcCtD
Carbachol—Loss of consciousness—Raloxifene—osteoporosis	0.00295	0.00349	CcSEcCtD
Carbachol—Dyspepsia—Etidronic acid—osteoporosis	0.00288	0.00341	CcSEcCtD
Carbachol—Arrhythmia—Risedronate—osteoporosis	0.00281	0.00333	CcSEcCtD
Carbachol—Infection—Estropipate—osteoporosis	0.00281	0.00333	CcSEcCtD
Carbachol—Flushing—Pamidronate—osteoporosis	0.00278	0.00328	CcSEcCtD
Carbachol—Infection—Alendronate—osteoporosis	0.00277	0.00327	CcSEcCtD
Carbachol—Cramp muscle—Estradiol—osteoporosis	0.00274	0.00324	CcSEcCtD
Carbachol—Infection—Raloxifene—osteoporosis	0.00272	0.00322	CcSEcCtD
Carbachol—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.0027	0.0032	CcSEcCtD
Carbachol—Flatulence—Risedronate—osteoporosis	0.0027	0.00319	CcSEcCtD
Carbachol—Shock—Raloxifene—osteoporosis	0.0027	0.00319	CcSEcCtD
Carbachol—Infection—Ibandronate—osteoporosis	0.00269	0.00319	CcSEcCtD
Carbachol—Shock—Ibandronate—osteoporosis	0.00267	0.00316	CcSEcCtD
Carbachol—Hyperhidrosis—Raloxifene—osteoporosis	0.00265	0.00313	CcSEcCtD
Carbachol—Muscle spasms—Risedronate—osteoporosis	0.00263	0.00312	CcSEcCtD
Carbachol—Asthma—Estradiol—osteoporosis	0.00263	0.00311	CcSEcCtD
Carbachol—Hyperhidrosis—Ibandronate—osteoporosis	0.00262	0.0031	CcSEcCtD
Carbachol—Nausea—Ergocalciferol—osteoporosis	0.00261	0.00309	CcSEcCtD
Carbachol—Abdominal pain—Etidronic acid—osteoporosis	0.00258	0.00306	CcSEcCtD
Carbachol—Sweating increased—Estradiol—osteoporosis	0.00256	0.00303	CcSEcCtD
Carbachol—Flushing—Zoledronate—osteoporosis	0.00254	0.003	CcSEcCtD
Carbachol—Abdominal discomfort—Estradiol—osteoporosis	0.00252	0.00298	CcSEcCtD
Carbachol—Muscle spasms—Pamidronate—osteoporosis	0.0025	0.00296	CcSEcCtD
Carbachol—Dyspepsia—Estropipate—osteoporosis	0.00249	0.00295	CcSEcCtD
Carbachol—Syncope—Risedronate—osteoporosis	0.00246	0.00291	CcSEcCtD
Carbachol—Dyspepsia—Alendronate—osteoporosis	0.00245	0.0029	CcSEcCtD
Carbachol—Arrhythmia—Zoledronate—osteoporosis	0.00244	0.00289	CcSEcCtD
Carbachol—Pain—Estropipate—osteoporosis	0.00242	0.00286	CcSEcCtD
Carbachol—Dyspepsia—Raloxifene—osteoporosis	0.00241	0.00285	CcSEcCtD
Carbachol—Loss of consciousness—Risedronate—osteoporosis	0.00241	0.00285	CcSEcCtD
Carbachol—Dyspepsia—Ibandronate—osteoporosis	0.00239	0.00283	CcSEcCtD
Carbachol—Pain—Alendronate—osteoporosis	0.00238	0.00282	CcSEcCtD
Carbachol—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00235	0.00278	CcSEcCtD
Carbachol—Pain—Raloxifene—osteoporosis	0.00234	0.00277	CcSEcCtD
Carbachol—Syncope—Pamidronate—osteoporosis	0.00233	0.00276	CcSEcCtD
Carbachol—Pain—Ibandronate—osteoporosis	0.00232	0.00274	CcSEcCtD
Carbachol—Loss of consciousness—Pamidronate—osteoporosis	0.00229	0.00271	CcSEcCtD
Carbachol—Muscle spasms—Zoledronate—osteoporosis	0.00229	0.00271	CcSEcCtD
Carbachol—Infection—Ethinyl Estradiol—osteoporosis	0.00228	0.0027	CcSEcCtD
Carbachol—Pain—Calcitriol—osteoporosis	0.00227	0.00269	CcSEcCtD
Carbachol—Flatulence—Conjugated Estrogens—osteoporosis	0.00226	0.00267	CcSEcCtD
Carbachol—Diarrhoea—Etidronic acid—osteoporosis	0.00224	0.00265	CcSEcCtD
Carbachol—Abdominal pain—Estropipate—osteoporosis	0.00224	0.00265	CcSEcCtD
Carbachol—Body temperature increased—Estropipate—osteoporosis	0.00224	0.00265	CcSEcCtD
Carbachol—Infection—Risedronate—osteoporosis	0.00222	0.00263	CcSEcCtD
Carbachol—Body temperature increased—Alendronate—osteoporosis	0.0022	0.00261	CcSEcCtD
Carbachol—Abdominal pain—Alendronate—osteoporosis	0.0022	0.00261	CcSEcCtD
Carbachol—Muscle spasms—Conjugated Estrogens—osteoporosis	0.0022	0.00261	CcSEcCtD
Carbachol—Shock—Risedronate—osteoporosis	0.0022	0.0026	CcSEcCtD
Carbachol—Abdominal pain—Raloxifene—osteoporosis	0.00217	0.00256	CcSEcCtD
Carbachol—Body temperature increased—Raloxifene—osteoporosis	0.00217	0.00256	CcSEcCtD
Carbachol—Abdominal pain—Ibandronate—osteoporosis	0.00214	0.00254	CcSEcCtD
Carbachol—Body temperature increased—Ibandronate—osteoporosis	0.00214	0.00254	CcSEcCtD
Carbachol—Syncope—Zoledronate—osteoporosis	0.00213	0.00252	CcSEcCtD
Carbachol—Infection—Pamidronate—osteoporosis	0.00211	0.0025	CcSEcCtD
Carbachol—Abdominal pain—Calcitriol—osteoporosis	0.0021	0.00248	CcSEcCtD
Carbachol—Body temperature increased—Calcitriol—osteoporosis	0.0021	0.00248	CcSEcCtD
Carbachol—Shock—Pamidronate—osteoporosis	0.00209	0.00247	CcSEcCtD
Carbachol—Loss of consciousness—Zoledronate—osteoporosis	0.00209	0.00247	CcSEcCtD
Carbachol—Vomiting—Etidronic acid—osteoporosis	0.00208	0.00246	CcSEcCtD
Carbachol—Rash—Etidronic acid—osteoporosis	0.00206	0.00244	CcSEcCtD
Carbachol—Dermatitis—Etidronic acid—osteoporosis	0.00206	0.00244	CcSEcCtD
Carbachol—Hyperhidrosis—Pamidronate—osteoporosis	0.00205	0.00243	CcSEcCtD
Carbachol—Syncope—Conjugated Estrogens—osteoporosis	0.00205	0.00243	CcSEcCtD
Carbachol—Headache—Etidronic acid—osteoporosis	0.00205	0.00242	CcSEcCtD
Carbachol—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00201	0.00238	CcSEcCtD
Carbachol—Hypotension—Pamidronate—osteoporosis	0.00199	0.00235	CcSEcCtD
Carbachol—Dyspepsia—Risedronate—osteoporosis	0.00197	0.00233	CcSEcCtD
Carbachol—Flushing—Estradiol—osteoporosis	0.00195	0.00231	CcSEcCtD
Carbachol—Nausea—Etidronic acid—osteoporosis	0.00194	0.0023	CcSEcCtD
Carbachol—Diarrhoea—Estropipate—osteoporosis	0.00194	0.00229	CcSEcCtD
Carbachol—Infection—Zoledronate—osteoporosis	0.00193	0.00228	CcSEcCtD
Carbachol—Pain—Risedronate—osteoporosis	0.00191	0.00226	CcSEcCtD
Carbachol—Shock—Zoledronate—osteoporosis	0.00191	0.00226	CcSEcCtD
Carbachol—Diarrhoea—Alendronate—osteoporosis	0.00191	0.00226	CcSEcCtD
Carbachol—Hyperhidrosis—Zoledronate—osteoporosis	0.00188	0.00222	CcSEcCtD
Carbachol—Diarrhoea—Raloxifene—osteoporosis	0.00187	0.00222	CcSEcCtD
Carbachol—Dyspepsia—Pamidronate—osteoporosis	0.00187	0.00221	CcSEcCtD
Carbachol—Dizziness—Estropipate—osteoporosis	0.00187	0.00221	CcSEcCtD
Carbachol—Infection—Conjugated Estrogens—osteoporosis	0.00186	0.0022	CcSEcCtD
Carbachol—Diarrhoea—Ibandronate—osteoporosis	0.00186	0.0022	CcSEcCtD
Carbachol—Dizziness—Alendronate—osteoporosis	0.00184	0.00218	CcSEcCtD
Carbachol—Shock—Conjugated Estrogens—osteoporosis	0.00184	0.00218	CcSEcCtD
Carbachol—Pain—Pamidronate—osteoporosis	0.00182	0.00215	CcSEcCtD
Carbachol—Diarrhoea—Calcitriol—osteoporosis	0.00182	0.00215	CcSEcCtD
Carbachol—Hypotension—Zoledronate—osteoporosis	0.00181	0.00215	CcSEcCtD
Carbachol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00181	0.00214	CcSEcCtD
Carbachol—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00181	0.00214	CcSEcCtD
Carbachol—Dizziness—Raloxifene—osteoporosis	0.00181	0.00214	CcSEcCtD
Carbachol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00181	0.00214	CcSEcCtD
Carbachol—Flatulence—Estradiol—osteoporosis	0.00181	0.00214	CcSEcCtD
Carbachol—Vomiting—Estropipate—osteoporosis	0.0018	0.00213	CcSEcCtD
Carbachol—Dizziness—Ibandronate—osteoporosis	0.00179	0.00212	CcSEcCtD
Carbachol—Rash—Estropipate—osteoporosis	0.00178	0.00211	CcSEcCtD
Carbachol—Dermatitis—Estropipate—osteoporosis	0.00178	0.00211	CcSEcCtD
Carbachol—Headache—Estropipate—osteoporosis	0.00177	0.0021	CcSEcCtD
Carbachol—Vomiting—Alendronate—osteoporosis	0.00177	0.0021	CcSEcCtD
Carbachol—Body temperature increased—Risedronate—osteoporosis	0.00177	0.00209	CcSEcCtD
Carbachol—Abdominal pain—Risedronate—osteoporosis	0.00177	0.00209	CcSEcCtD
Carbachol—Muscle spasms—Estradiol—osteoporosis	0.00176	0.00209	CcSEcCtD
Carbachol—Rash—Alendronate—osteoporosis	0.00176	0.00208	CcSEcCtD
Carbachol—Dermatitis—Alendronate—osteoporosis	0.00175	0.00208	CcSEcCtD
Carbachol—Hypotension—Conjugated Estrogens—osteoporosis	0.00175	0.00207	CcSEcCtD
Carbachol—Headache—Alendronate—osteoporosis	0.00175	0.00207	CcSEcCtD
Carbachol—Vomiting—Raloxifene—osteoporosis	0.00174	0.00206	CcSEcCtD
Carbachol—Rash—Raloxifene—osteoporosis	0.00173	0.00204	CcSEcCtD
Carbachol—Dermatitis—Raloxifene—osteoporosis	0.00173	0.00204	CcSEcCtD
Carbachol—Vomiting—Ibandronate—osteoporosis	0.00172	0.00204	CcSEcCtD
Carbachol—Headache—Raloxifene—osteoporosis	0.00172	0.00203	CcSEcCtD
Carbachol—Rash—Ibandronate—osteoporosis	0.00171	0.00202	CcSEcCtD
Carbachol—Dermatitis—Ibandronate—osteoporosis	0.00171	0.00202	CcSEcCtD
Carbachol—Dyspepsia—Zoledronate—osteoporosis	0.00171	0.00202	CcSEcCtD
Carbachol—Headache—Ibandronate—osteoporosis	0.0017	0.00201	CcSEcCtD
Carbachol—Vomiting—Calcitriol—osteoporosis	0.00169	0.002	CcSEcCtD
Carbachol—Nausea—Estropipate—osteoporosis	0.00168	0.00199	CcSEcCtD
Carbachol—Abdominal pain—Pamidronate—osteoporosis	0.00168	0.00199	CcSEcCtD
Carbachol—Body temperature increased—Pamidronate—osteoporosis	0.00168	0.00199	CcSEcCtD
Carbachol—Rash—Calcitriol—osteoporosis	0.00167	0.00198	CcSEcCtD
Carbachol—Dermatitis—Calcitriol—osteoporosis	0.00167	0.00198	CcSEcCtD
Carbachol—Headache—Calcitriol—osteoporosis	0.00166	0.00197	CcSEcCtD
Carbachol—Pain—Zoledronate—osteoporosis	0.00166	0.00196	CcSEcCtD
Carbachol—Nausea—Alendronate—osteoporosis	0.00165	0.00196	CcSEcCtD
Carbachol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00165	0.00195	CcSEcCtD
Carbachol—Syncope—Estradiol—osteoporosis	0.00164	0.00194	CcSEcCtD
Carbachol—Nausea—Raloxifene—osteoporosis	0.00163	0.00193	CcSEcCtD
Carbachol—Nausea—Ibandronate—osteoporosis	0.00161	0.00191	CcSEcCtD
Carbachol—Loss of consciousness—Estradiol—osteoporosis	0.00161	0.00191	CcSEcCtD
Carbachol—Pain—Conjugated Estrogens—osteoporosis	0.0016	0.00189	CcSEcCtD
Carbachol—Nausea—Calcitriol—osteoporosis	0.00158	0.00187	CcSEcCtD
Carbachol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00157	0.00186	CcSEcCtD
Carbachol—Abdominal pain—Zoledronate—osteoporosis	0.00153	0.00182	CcSEcCtD
Carbachol—Body temperature increased—Zoledronate—osteoporosis	0.00153	0.00182	CcSEcCtD
Carbachol—Diarrhoea—Risedronate—osteoporosis	0.00153	0.00181	CcSEcCtD
Carbachol—Dizziness—Ethinyl Estradiol—osteoporosis	0.00152	0.00179	CcSEcCtD
Carbachol—Infection—Estradiol—osteoporosis	0.00149	0.00176	CcSEcCtD
Carbachol—Dizziness—Risedronate—osteoporosis	0.00148	0.00175	CcSEcCtD
Carbachol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00148	0.00175	CcSEcCtD
Carbachol—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00148	0.00175	CcSEcCtD
Carbachol—Shock—Estradiol—osteoporosis	0.00147	0.00174	CcSEcCtD
Carbachol—Vomiting—Ethinyl Estradiol—osteoporosis	0.00146	0.00172	CcSEcCtD
Carbachol—Diarrhoea—Pamidronate—osteoporosis	0.00145	0.00172	CcSEcCtD
Carbachol—Hyperhidrosis—Estradiol—osteoporosis	0.00145	0.00171	CcSEcCtD
Carbachol—Rash—Ethinyl Estradiol—osteoporosis	0.00145	0.00171	CcSEcCtD
Carbachol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00144	0.00171	CcSEcCtD
Carbachol—Headache—Ethinyl Estradiol—osteoporosis	0.00144	0.0017	CcSEcCtD
Carbachol—Vomiting—Risedronate—osteoporosis	0.00142	0.00168	CcSEcCtD
Carbachol—Rash—Risedronate—osteoporosis	0.00141	0.00167	CcSEcCtD
Carbachol—Dermatitis—Risedronate—osteoporosis	0.00141	0.00167	CcSEcCtD
Carbachol—Dizziness—Pamidronate—osteoporosis	0.00141	0.00166	CcSEcCtD
Carbachol—Headache—Risedronate—osteoporosis	0.0014	0.00166	CcSEcCtD
Carbachol—Nausea—Ethinyl Estradiol—osteoporosis	0.00136	0.00161	CcSEcCtD
Carbachol—Vomiting—Pamidronate—osteoporosis	0.00135	0.0016	CcSEcCtD
Carbachol—Rash—Pamidronate—osteoporosis	0.00134	0.00159	CcSEcCtD
Carbachol—Dermatitis—Pamidronate—osteoporosis	0.00134	0.00158	CcSEcCtD
Carbachol—Headache—Pamidronate—osteoporosis	0.00133	0.00158	CcSEcCtD
Carbachol—Diarrhoea—Zoledronate—osteoporosis	0.00133	0.00157	CcSEcCtD
Carbachol—Nausea—Risedronate—osteoporosis	0.00133	0.00157	CcSEcCtD
Carbachol—Dyspepsia—Estradiol—osteoporosis	0.00132	0.00156	CcSEcCtD
Carbachol—Dizziness—Zoledronate—osteoporosis	0.00128	0.00152	CcSEcCtD
Carbachol—Pain—Estradiol—osteoporosis	0.00128	0.00151	CcSEcCtD
Carbachol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00128	0.00151	CcSEcCtD
Carbachol—Nausea—Pamidronate—osteoporosis	0.00126	0.00149	CcSEcCtD
Carbachol—Dizziness—Conjugated Estrogens—osteoporosis	0.00124	0.00146	CcSEcCtD
Carbachol—Vomiting—Zoledronate—osteoporosis	0.00123	0.00146	CcSEcCtD
Carbachol—Rash—Zoledronate—osteoporosis	0.00122	0.00145	CcSEcCtD
Carbachol—Dermatitis—Zoledronate—osteoporosis	0.00122	0.00145	CcSEcCtD
Carbachol—Headache—Zoledronate—osteoporosis	0.00122	0.00144	CcSEcCtD
Carbachol—Vomiting—Conjugated Estrogens—osteoporosis	0.00119	0.00141	CcSEcCtD
Carbachol—Body temperature increased—Estradiol—osteoporosis	0.00118	0.0014	CcSEcCtD
Carbachol—Abdominal pain—Estradiol—osteoporosis	0.00118	0.0014	CcSEcCtD
Carbachol—Rash—Conjugated Estrogens—osteoporosis	0.00118	0.00139	CcSEcCtD
Carbachol—Dermatitis—Conjugated Estrogens—osteoporosis	0.00118	0.00139	CcSEcCtD
Carbachol—Headache—Conjugated Estrogens—osteoporosis	0.00117	0.00139	CcSEcCtD
Carbachol—Nausea—Zoledronate—osteoporosis	0.00115	0.00136	CcSEcCtD
Carbachol—Nausea—Conjugated Estrogens—osteoporosis	0.00111	0.00131	CcSEcCtD
Carbachol—Diarrhoea—Estradiol—osteoporosis	0.00102	0.00121	CcSEcCtD
Carbachol—Dizziness—Estradiol—osteoporosis	0.000989	0.00117	CcSEcCtD
Carbachol—Vomiting—Estradiol—osteoporosis	0.000951	0.00113	CcSEcCtD
Carbachol—Rash—Estradiol—osteoporosis	0.000943	0.00112	CcSEcCtD
Carbachol—Dermatitis—Estradiol—osteoporosis	0.000942	0.00111	CcSEcCtD
Carbachol—Headache—Estradiol—osteoporosis	0.000937	0.00111	CcSEcCtD
Carbachol—Nausea—Estradiol—osteoporosis	0.000888	0.00105	CcSEcCtD
Carbachol—CHRM3—Signaling by GPCR—MGLL—osteoporosis	0.000252	0.00186	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—MGLL—osteoporosis	0.00025	0.00184	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MGLL—osteoporosis	0.000249	0.00184	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PKM—osteoporosis	0.000248	0.00183	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—FDPS—osteoporosis	0.000248	0.00183	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—LRP5—osteoporosis	0.000243	0.00179	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CALCA—osteoporosis	0.000238	0.00176	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CYP27A1—osteoporosis	0.000238	0.00176	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CALCA—osteoporosis	0.000237	0.00175	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PGLS—osteoporosis	0.000235	0.00174	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GPD2—osteoporosis	0.000235	0.00174	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CALCA—osteoporosis	0.000235	0.00173	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000233	0.00172	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000233	0.00172	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—LRP6—osteoporosis	0.000232	0.00171	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ACP5—osteoporosis	0.000231	0.00171	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PTHLH—osteoporosis	0.000231	0.0017	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000228	0.00169	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000217	0.0016	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000215	0.00159	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ATIC—osteoporosis	0.000215	0.00159	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PNP—osteoporosis	0.000215	0.00159	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—TPI1—osteoporosis	0.000215	0.00159	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000215	0.00158	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000209	0.00154	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SOST—osteoporosis	0.000208	0.00154	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SOST—osteoporosis	0.000207	0.00153	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000207	0.00153	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SOST—osteoporosis	0.000205	0.00152	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CALCA—osteoporosis	0.000203	0.0015	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—POMC—osteoporosis	0.000203	0.0015	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—P4HB—osteoporosis	0.000202	0.00149	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GAPDH—osteoporosis	0.000199	0.00147	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TLN1—osteoporosis	0.000196	0.00145	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—RAP1A—osteoporosis	0.000193	0.00143	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CALCR—osteoporosis	0.000188	0.00139	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTH1R—osteoporosis	0.000188	0.00139	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CALCR—osteoporosis	0.000188	0.00138	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTH1R—osteoporosis	0.000188	0.00138	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CALCR—osteoporosis	0.000186	0.00137	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTH1R—osteoporosis	0.000186	0.00137	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PTH—osteoporosis	0.000184	0.00136	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PTH—osteoporosis	0.000184	0.00136	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CA2—osteoporosis	0.000183	0.00135	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—OXCT1—osteoporosis	0.000183	0.00135	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PTH—osteoporosis	0.000182	0.00134	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CNR2—osteoporosis	0.00018	0.00133	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CNR2—osteoporosis	0.000179	0.00132	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—MGLL—osteoporosis	0.000178	0.00132	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—IGF1—osteoporosis	0.000178	0.00131	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	0.000177	0.00131	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—P4HB—osteoporosis	0.000169	0.00125	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000169	0.00124	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PTH—osteoporosis	0.000167	0.00124	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PTH—osteoporosis	0.000167	0.00123	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PTH—osteoporosis	0.000165	0.00122	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTH—osteoporosis	0.000164	0.00121	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000163	0.00121	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CNR2—osteoporosis	0.000163	0.0012	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000163	0.0012	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CNR2—osteoporosis	0.000163	0.0012	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RAP1A—osteoporosis	0.000162	0.00119	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000161	0.00119	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CNR2—osteoporosis	0.000161	0.00119	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CNR2—osteoporosis	0.00016	0.00118	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NFATC1—osteoporosis	0.000158	0.00116	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DKK1—osteoporosis	0.000156	0.00115	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ENO1—osteoporosis	0.000156	0.00115	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PSMA5—osteoporosis	0.000154	0.00114	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PSMA2—osteoporosis	0.000154	0.00114	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—WNT1—osteoporosis	0.000153	0.00113	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—WNT1—osteoporosis	0.000153	0.00113	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	0.000153	0.00113	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PTHLH—osteoporosis	0.000152	0.00112	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000152	0.00112	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—IDH2—osteoporosis	0.000152	0.00112	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—WNT1—osteoporosis	0.000151	0.00112	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	0.000151	0.00111	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—WNT1—osteoporosis	0.000151	0.00111	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MGLL—osteoporosis	0.00015	0.0011	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MGLL—osteoporosis	0.000149	0.0011	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MGLL—osteoporosis	0.000148	0.00109	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—FGA—osteoporosis	0.000147	0.00108	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LRP5—osteoporosis	0.000146	0.00108	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LRP5—osteoporosis	0.000145	0.00107	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—ADCY5—osteoporosis	0.000144	0.00107	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LRP5—osteoporosis	0.000144	0.00106	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CYP27A1—osteoporosis	0.000142	0.00105	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LRP6—osteoporosis	0.00014	0.00103	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LRP6—osteoporosis	0.000139	0.00103	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	0.000139	0.00102	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ACP5—osteoporosis	0.000139	0.00102	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	0.000138	0.00102	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LRP6—osteoporosis	0.000138	0.00102	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	0.000137	0.00101	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTHLH—osteoporosis	0.000136	0.00101	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—BMP2—osteoporosis	0.000136	0.00101	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	0.000134	0.000992	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	0.000134	0.000989	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—FGB—osteoporosis	0.000133	0.000985	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	0.000133	0.00098	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—TPI1—osteoporosis	0.000129	0.000951	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PSMA2—osteoporosis	0.000129	0.00095	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PSMA5—osteoporosis	0.000129	0.00095	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CYP19A1—osteoporosis	0.000125	0.000922	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—POMC—osteoporosis	0.000124	0.000919	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—POMC—osteoporosis	0.000124	0.000916	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—POMC—osteoporosis	0.000123	0.000907	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000122	0.000903	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CALCA—osteoporosis	0.000122	0.000901	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CALCA—osteoporosis	0.000122	0.000898	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—P4HB—osteoporosis	0.000121	0.000894	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CALCA—osteoporosis	0.000121	0.00089	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CALCA—osteoporosis	0.00012	0.000886	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GAPDH—osteoporosis	0.000119	0.000878	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TLN1—osteoporosis	0.000118	0.00087	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TLN1—osteoporosis	0.000117	0.000867	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TLN1—osteoporosis	0.000116	0.000859	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—RAP1A—osteoporosis	0.000116	0.000855	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KL—osteoporosis	0.000109	0.000804	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—TGFB1—osteoporosis	0.000107	0.000788	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—POMC—osteoporosis	0.000106	0.000785	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL6R—osteoporosis	0.000104	0.000765	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ADCY5—osteoporosis	0.000102	0.000754	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GPX1—osteoporosis	0.000102	0.000751	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—P4HB—osteoporosis	0.000102	0.00075	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—P4HB—osteoporosis	0.000101	0.000748	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—IL6—osteoporosis	0.000101	0.000747	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—P4HB—osteoporosis	0.0001	0.00074	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTH—osteoporosis	9.89e-05	0.00073	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTH—osteoporosis	9.85e-05	0.000727	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTH—osteoporosis	9.76e-05	0.00072	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RAP1A—osteoporosis	9.72e-05	0.000717	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RAP1A—osteoporosis	9.68e-05	0.000715	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CNR2—osteoporosis	9.63e-05	0.000711	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CNR2—osteoporosis	9.6e-05	0.000709	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	9.59e-05	0.000708	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RAP1A—osteoporosis	9.59e-05	0.000708	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	9.56e-05	0.000706	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	9.56e-05	0.000706	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	9.53e-05	0.000704	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CNR2—osteoporosis	9.51e-05	0.000702	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NFATC1—osteoporosis	9.48e-05	0.0007	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NFATC1—osteoporosis	9.45e-05	0.000697	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	9.44e-05	0.000697	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DKK1—osteoporosis	9.4e-05	0.000694	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—MTHFR—osteoporosis	9.39e-05	0.000693	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DKK1—osteoporosis	9.37e-05	0.000692	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ENO1—osteoporosis	9.36e-05	0.000691	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NFATC1—osteoporosis	9.36e-05	0.000691	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DKK1—osteoporosis	9.28e-05	0.000685	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PSMA5—osteoporosis	9.23e-05	0.000681	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PSMA2—osteoporosis	9.23e-05	0.000681	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—WNT1—osteoporosis	9.06e-05	0.000669	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—WNT1—osteoporosis	9.03e-05	0.000666	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—WNT1—osteoporosis	8.94e-05	0.00066	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGA—osteoporosis	8.81e-05	0.00065	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGA—osteoporosis	8.78e-05	0.000648	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGA—osteoporosis	8.7e-05	0.000642	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	8.68e-05	0.000641	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	8.66e-05	0.000639	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	8.57e-05	0.000633	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ADCY5—osteoporosis	8.54e-05	0.00063	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SPP1—osteoporosis	8.26e-05	0.00061	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTHLH—osteoporosis	8.19e-05	0.000605	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—BMP2—osteoporosis	8.19e-05	0.000605	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTHLH—osteoporosis	8.17e-05	0.000603	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—BMP2—osteoporosis	8.17e-05	0.000603	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTHLH—osteoporosis	8.09e-05	0.000597	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—BMP2—osteoporosis	8.09e-05	0.000597	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGB—osteoporosis	8.02e-05	0.000592	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGB—osteoporosis	7.99e-05	0.00059	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGB—osteoporosis	7.91e-05	0.000584	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PSMA2—osteoporosis	7.74e-05	0.000571	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PSMA5—osteoporosis	7.74e-05	0.000571	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PSMA2—osteoporosis	7.71e-05	0.000569	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PSMA5—osteoporosis	7.71e-05	0.000569	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PSMA2—osteoporosis	7.64e-05	0.000564	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PSMA5—osteoporosis	7.64e-05	0.000564	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—POMC—osteoporosis	7.51e-05	0.000554	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CYP19A1—osteoporosis	7.48e-05	0.000552	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IRS2—osteoporosis	7.47e-05	0.000551	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—LEP—osteoporosis	7.31e-05	0.000539	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CALCA—osteoporosis	7.21e-05	0.000532	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CALCA—osteoporosis	7.19e-05	0.000531	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CALCA—osteoporosis	7.12e-05	0.000525	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—POMC—osteoporosis	7.03e-05	0.000519	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—POMC—osteoporosis	7.01e-05	0.000518	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ESR1—osteoporosis	6.98e-05	0.000515	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—POMC—osteoporosis	6.94e-05	0.000513	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KL—osteoporosis	6.55e-05	0.000483	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KL—osteoporosis	6.53e-05	0.000482	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IRS1—osteoporosis	6.52e-05	0.000481	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KL—osteoporosis	6.46e-05	0.000477	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—POMC—osteoporosis	6.39e-05	0.000471	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—POMC—osteoporosis	6.37e-05	0.00047	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—POMC—osteoporosis	6.31e-05	0.000465	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—POMC—osteoporosis	6.28e-05	0.000463	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6R—osteoporosis	6.23e-05	0.00046	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6R—osteoporosis	6.21e-05	0.000458	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6R—osteoporosis	6.15e-05	0.000454	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6R—osteoporosis	6.12e-05	0.000452	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ADCY5—osteoporosis	6.12e-05	0.000451	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GPX1—osteoporosis	6.09e-05	0.00045	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IGF1—osteoporosis	6.04e-05	0.000446	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—MTHFR—osteoporosis	5.62e-05	0.000415	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADCY5—osteoporosis	5.13e-05	0.000379	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADCY5—osteoporosis	5.11e-05	0.000377	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADCY5—osteoporosis	5.06e-05	0.000374	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SPP1—osteoporosis	4.96e-05	0.000366	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SPP1—osteoporosis	4.95e-05	0.000365	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SPP1—osteoporosis	4.9e-05	0.000362	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL6—osteoporosis	4.62e-05	0.000341	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—POMC—osteoporosis	4.5e-05	0.000332	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IRS2—osteoporosis	4.49e-05	0.000331	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IRS2—osteoporosis	4.47e-05	0.00033	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IRS2—osteoporosis	4.43e-05	0.000327	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LEP—osteoporosis	4.39e-05	0.000324	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LEP—osteoporosis	4.38e-05	0.000323	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LEP—osteoporosis	4.34e-05	0.00032	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ESR1—osteoporosis	4.19e-05	0.00031	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ESR1—osteoporosis	4.18e-05	0.000309	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ESR1—osteoporosis	4.14e-05	0.000306	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IRS1—osteoporosis	3.92e-05	0.000289	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IRS1—osteoporosis	3.91e-05	0.000288	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IRS1—osteoporosis	3.87e-05	0.000286	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—POMC—osteoporosis	3.77e-05	0.000279	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—POMC—osteoporosis	3.76e-05	0.000278	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—POMC—osteoporosis	3.72e-05	0.000275	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6R—osteoporosis	3.68e-05	0.000272	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6R—osteoporosis	3.67e-05	0.000271	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6R—osteoporosis	3.63e-05	0.000268	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1—osteoporosis	3.63e-05	0.000268	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MYC—osteoporosis	3.63e-05	0.000268	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TGFB1—osteoporosis	3.62e-05	0.000267	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1—osteoporosis	3.62e-05	0.000267	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1—osteoporosis	3.58e-05	0.000264	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6—osteoporosis	2.78e-05	0.000205	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6—osteoporosis	2.77e-05	0.000204	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6—osteoporosis	2.74e-05	0.000202	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6—osteoporosis	2.73e-05	0.000201	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MYC—osteoporosis	2.18e-05	0.000161	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TGFB1—osteoporosis	2.18e-05	0.000161	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MYC—osteoporosis	2.17e-05	0.00016	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TGFB1—osteoporosis	2.17e-05	0.00016	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MYC—osteoporosis	2.15e-05	0.000159	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TGFB1—osteoporosis	2.15e-05	0.000159	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6—osteoporosis	1.64e-05	0.000121	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6—osteoporosis	1.63e-05	0.000121	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6—osteoporosis	1.62e-05	0.000119	CbGpPWpGaD
